Found: 107
Select item for more details and to access through your institution.
Accelerated long-term forgetting in individuals with subjective cognitive decline and amyloid-β positivity.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The effect of MAPT H1 and APOE 4 on transition from mild cognitive impairment to dementia.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
The Effect of MAPT H1 and APOE ℇ4 on Transition from Mild Cognitive Impairment to Dementia.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 22, n. 4, p. 1065, doi. 10.3233/JAD-2010-101011
- By:
- Publication type:
- Article
Brain Perfusion Correlates of Visuoperceptual Deficits in Mild Cognitive Impairment and Mild Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 21, n. 2, p. 557, doi. 10.3233/JAD-2010-091069
- By:
- Publication type:
- Article
CALHM1 P86L Polymorphism is Associated with Late-Onset Alzheimer's Disease in a Recessive Model.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 20, n. 1, p. 247, doi. 10.3233/JAD-2010-1357
- By:
- Publication type:
- Article
GOLPH2 Gene Markers are Not Associated with Alzheimer's Disease in a Sample of the Spanish Population.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 18, n. 4, p. 751, doi. 10.3233/JAD-2009-1200
- By:
- Publication type:
- Article
Plasma lipids are associated with white matter microstructural changes and axonal degeneration.
- Published in:
- Brain Imaging & Behavior, 2021, v. 15, n. 2, p. 1043, doi. 10.1007/s11682-020-00311-9
- By:
- Publication type:
- Article
Actitudes, dudas y conocimientos de los colectivos implicados en la atención del paciente con Alzheimer: resultados de la encuesta del proyecto kNOW Alzheimer.
- Published in:
- Farmacéuticos Comunitarios, 2016, v. 8, n. 1, p. 13, doi. 10.5672/FC.2173-9218.(2016/Vol8).001.03
- By:
- Publication type:
- Article
Fitting the epidemiology and neuropathology of the early stages of Alzheimer's disease to prevent dementia.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-014-0079-9
- By:
- Publication type:
- Article
Fitting the epidemiology and neuropathology of the early stages of Alzheimer's disease to prevent dementia.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-014-0079-9
- By:
- Publication type:
- Article
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
- Published in:
- 2020
- By:
- Publication type:
- journal article
On the Selection of Non-Invasive Methods Based on Speech Analysis Oriented to Automatic Alzheimer Disease Diagnosis.
- Published in:
- Sensors (14248220), 2013, v. 13, n. 5, p. 6730, doi. 10.3390/s130506730
- By:
- Publication type:
- Article
Accelerated long‐term forgetting over three months in asymptomatic APOE ɛ4 carriers.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 2, p. 477, doi. 10.1002/acn3.51245
- By:
- Publication type:
- Article
Functional brain network centrality is related to APOE genotype in cognitively normal elderly.
- Published in:
- Brain & Behavior, 2018, v. 8, n. 9, p. 1, doi. 10.1002/brb3.1080
- By:
- Publication type:
- Article
Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease.
- Published in:
- CNS Neuroscience & Therapeutics, 2010, v. 16, n. 4, p. 246, doi. 10.1111/j.1755-5949.2010.00141.x
- By:
- Publication type:
- Article
Unlocking Preclinical Alzheimer's: A Multi-Year Label-Free In Vitro Raman Spectroscopy Study Empowered by Chemometrics.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 9, p. 4737, doi. 10.3390/ijms25094737
- By:
- Publication type:
- Article
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12286
- By:
- Publication type:
- Article
Ecological assessment of executive functions in mild cognitive impairment and mild Alzheimer's disease.
- Published in:
- Journal of the International Neuropsychological Society, 2009, v. 15, n. 5, p. 751, doi. 10.1017/S135561770999035X
- By:
- Publication type:
- Article
CSF proteomic profiling of mild cognitive impairment individuals with suspected non‐Alzheimer's disease pathophysiology: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047247
- By:
- Publication type:
- Article
Synaptic proteins relate to memory scores in preclinical Alzheimer's disease and cognitively healthy controls depending on amyloid: Molecular and cell biology/synaptic disruption.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046102
- By:
- Publication type:
- Article
DNA methylation differences associated with peripheral biomarkers in the EMIF‐AD cohort: Biomarkers (non‐neuroimaging) / Novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045853
- By:
- Publication type:
- Article
Current status and quantitative results of the AMYPAD prognostic and natural history study: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044711
- By:
- Publication type:
- Article
Cognitive results after a FINGER‐like one‐year randomized controlled multidomain intervention: The GOIZ ZAINDU pilot project: Prevention (nonpharmacological) / Multidomain.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042440
- By:
- Publication type:
- Article
Accelerated long‐term forgetting over six months in cognitively normal APOE ɛ4 carriers: Neuropsychology/Early detection of cognitive decline with neuropsychological tests.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041928
- By:
- Publication type:
- Article
O5‐05‐03: ASSOCIATIONS BETWEEN CEREBROSPINAL FLUID NEURODEGENERATIVE MARKERS, NEUROFILAMENT‐LIGHT AND TOTAL TAU AND CEREBROVASCULAR IMAGING MARKERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1626, doi. 10.1016/j.jalz.2019.06.4860
- By:
- Publication type:
- Article
P4‐525: ASSOCIATION OF CSF TAU WITH HYPERPLASTICITY IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1515, doi. 10.1016/j.jalz.2019.08.072
- By:
- Publication type:
- Article
P4‐210: DISENTANGLING THE RELATIONSHIP BETWEEN SYNAPTIC AND NEURODEGENERATION CEREBROSPINAL FLUID BIOMARKERS IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1356, doi. 10.1016/j.jalz.2019.06.3873
- By:
- Publication type:
- Article
P4‐005: GOIZ ZAINDU: A FINGER‐ADAPTED MULTIDOMAIN LIFESTYLE INTERVENTION TO PREVENT DEMENTIA IN THE BASQUE COUNTRY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1275, doi. 10.1016/j.jalz.2019.06.3664
- By:
- Publication type:
- Article
P2‐242: PATHOPHYSIOLOGICAL SUBTYPES OF ALZHEIMER'S DISEASE BASED ON CEREBROSPINAL FLUID PROTEOMICS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P675, doi. 10.1016/j.jalz.2019.06.2649
- By:
- Publication type:
- Article
Inflammatory biomarkers in Alzheimer's disease plasma.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 6, p. 776, doi. 10.1016/j.jalz.2019.03.007
- By:
- Publication type:
- Article
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 6, p. 742, doi. 10.1016/j.jalz.2019.01.015
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 5, p. 644, doi. 10.1016/j.jalz.2019.01.004
- By:
- Publication type:
- Article
P3‐233: PLASMA PRIMARY FATTY AMIDES ASSOCIATE TO CSF AMYLOID LEVELS AND ALZHEIMER'S DISEASE PROGRESSION IN THE EMIF‐AD BIOMARKER DISCOVERY COHORT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1161, doi. 10.1016/j.jalz.2018.06.1592
- By:
- Publication type:
- Article
P2‐458: PREDICTING COGNITIVE DECLINE THROUGH STRUCTURAL MRI BIOMARKERS: RESULTS FROM THE EMIF‐AD BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P895, doi. 10.1016/j.jalz.2018.06.1151
- By:
- Publication type:
- Article
P2‐270: INCREASED CSF AMYLOID‐β 1‐38 AND 1‐40 CONCENTRATIONS IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT WITH TAU BUT WITHOUT AMYLOID PATHOPHYSIOLOGY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P780, doi. 10.1016/j.jalz.2018.06.959
- By:
- Publication type:
- Article
P2‐262: A CEREBROSPINAL FLUID PANEL OF SYNAPTIC PROTEINS ACROSS THE ENTIRE ALZHEIMER'S DISEASE CONTINUUM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P777, doi. 10.1016/j.jalz.2018.06.951
- By:
- Publication type:
- Article
F1‐02‐04: GENOMICS AND EPIGENOMICS ANALYSES IN THE EMIF‐AD MULTIMODAL BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P204, doi. 10.1016/j.jalz.2018.06.2310
- By:
- Publication type:
- Article
F1‐02‐03: MRI PREDICTORS OF AMYLOID PATHOLOGY: RESULTS FROM THE EMIF‐AD BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P202, doi. 10.1016/j.jalz.2018.06.2309
- By:
- Publication type:
- Article
F1‐02‐01: RELATING CSF MARKERS NEUROGRANIN, NEUROFILAMENT‐LIGHT AND YKL‐40 TO Aβ, APOE ε4 AND COGNITION: RESULTS FROM THE EMIF‐AD MULTIMODAL BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P201, doi. 10.1016/j.jalz.2018.06.2307
- By:
- Publication type:
- Article
European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 6, p. 837, doi. 10.1016/j.jalz.2018.02.010
- By:
- Publication type:
- Article
LONGITUDINAL CEREBROSPINAL FLUID BIOMARKER TRAJECTORIES ALONG THE ALZHEIMER'S DISEASE CONTINUUM: A MULTICENTRE EUROPEAN STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P924, doi. 10.1016/j.jalz.2017.07.359
- By:
- Publication type:
- Article
DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN (CSF Aβ OR AMYLOID-PET) IN THE EMIF-AD BIOMARKER DISCOVERY COHORT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P361, doi. 10.1016/j.jalz.2017.06.305
- By:
- Publication type:
- Article
EUROPEAN MEDICAL INFORMATION FRAMEWORK FOR ALZHEIMER’S DISEASE (EMIF-AD): THE BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P691, doi. 10.1016/j.jalz.2017.06.864
- By:
- Publication type:
- Article
Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, n. 2, p. 154, doi. 10.1016/j.jalz.2015.08.003
- By:
- Publication type:
- Article
Impact of ApoE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P194, doi. 10.1016/j.jalz.2015.06.130
- By:
- Publication type:
- Article
Grey matter network disruptions are related to amyloid-beta in cognitively healthy elderly.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P11, doi. 10.1016/j.jalz.2015.06.017
- By:
- Publication type:
- Article
Grey matter network disruptions are related to amyloid beta in cognitively healthy elderly.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P689, doi. 10.1016/j.jalz.2015.06.017
- By:
- Publication type:
- Article
Impact of ApoE-Ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P73, doi. 10.1016/j.jalz.2015.06.130
- By:
- Publication type:
- Article
Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lp feasibility study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P297, doi. 10.1016/j.jalz.2015.07.408
- By:
- Publication type:
- Article